Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Retatrutide (LY3437943) is a first-in-class triple-receptor agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
Over days of storage, bacteria multiply and produce endotoxins that could compromise your research results or cause adverse reactions
Phone: 1-833-4LOWTEE Email: [email protected] *No guarantee of specific results
I can get #100 insulin syringes at Walgreens for under $20
Unlike some peptides where receptor downregulation requires cycling, GLP-1 receptors don't follow the same pattern
US$ 27.18
US$ 21.80
US$ 23.63
US$ 29.22
US$ 26.71
US$ 29.96
